Mainz Biomed
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|---|
Cash | 889 | 1,911 | 6,235 | 977 |
Basic Shares | 9,780 | 4,091 | 2,319 | 639 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $537 | $893 | $895 | $529 |
Gross Profit | 389 | 574 | 509 | 182 |
EBITDA | -19,558 | -24,869 | -25,718 | |
EBIT | -20,575 | -25,736 | -26,098 | |
Net Income | -16,210 | -21,650 | -26,295 | -26,387 |
Net Change In Cash | 537 | 893 | 895 | 529 |
Free Cash Flow | -12,030 | -17,344 | -23,837 | -15,428 |
Cash | 889 | 6,235 | 7,070 | 17,141 |
Basic Shares | 9,060 | 968 | 406 | 353 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-03-31 | -$9.79 |
2023-09-30 | -$15.78 |
2023-06-30 | -$22.12 |
2023-03-31 | -$17.86 |